Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Rosenberg

Showing results (1-10 of 441) with videos related to

Pageof 45
Sort By:
The New England Journal of Medicine|April 9, 2004
Shedding light on immunotherapy for cancerSteven A Rosenberg
Science (New York, N.Y.)|July 4, 2024
Lymphocytes as a living drug for cancerSteven A Rosenberg
Cancer Gene Therapy|February 19, 2014
Finding suitable targets is the major obstacle to cancer gene therapySteven A Rosenberg
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2010
Of mice, not men: no evidence for graft-versus-host disease in humans receiving T-cell receptor-transduced autologous T cellsSteven A Rosenberg
Molecular Medicine (Cambridge, Mass.)|November 3, 2021
Correction to: A Journey in Science: Immersion in the search for effective cancer immunotherapiesSteven A Rosenberg
Nature Clinical Practice. Oncology|August 31, 2007
Interleukin 2 for patients with renal cancerSteven A Rosenberg
Science Translational Medicine|March 31, 2012
Raising the bar: the curative potential of human cancer immunotherapySteven A Rosenberg
Nature Clinical Practice. Oncology|November 3, 2005
Cancer immunotherapy comes of ageSteven A Rosenberg
Molecular Medicine (Cambridge, Mass.)|June 17, 2021
Immersion in the search for effective cancer immunotherapiesSteven A Rosenberg
Nature Clinical Practice. Oncology|December 22, 2007
Why perform sentinel-lymph-node biopsy in patients with melanoma?Steven A Rosenberg
Pageof 45

Showing results (1-10 of 441) with videos related to

Sort By:
Pageof 45
The New England Journal of Medicine|April 9, 2004
Shedding light on immunotherapy for cancerSteven A Rosenberg
Science (New York, N.Y.)|July 4, 2024
Lymphocytes as a living drug for cancerSteven A Rosenberg
Cancer Gene Therapy|February 19, 2014
Finding suitable targets is the major obstacle to cancer gene therapySteven A Rosenberg
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2010
Of mice, not men: no evidence for graft-versus-host disease in humans receiving T-cell receptor-transduced autologous T cellsSteven A Rosenberg
Molecular Medicine (Cambridge, Mass.)|November 3, 2021
Correction to: A Journey in Science: Immersion in the search for effective cancer immunotherapiesSteven A Rosenberg
Nature Clinical Practice. Oncology|August 31, 2007
Interleukin 2 for patients with renal cancerSteven A Rosenberg
Science Translational Medicine|March 31, 2012
Raising the bar: the curative potential of human cancer immunotherapySteven A Rosenberg
Nature Clinical Practice. Oncology|November 3, 2005
Cancer immunotherapy comes of ageSteven A Rosenberg
Molecular Medicine (Cambridge, Mass.)|June 17, 2021
Immersion in the search for effective cancer immunotherapiesSteven A Rosenberg
Nature Clinical Practice. Oncology|December 22, 2007
Why perform sentinel-lymph-node biopsy in patients with melanoma?Steven A Rosenberg
Pageof 45